Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Vogler

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Research in Social & Administrative Pharmacy : RSAP|February 18, 2018
Medication wasted - Contents and costs of medicines ending up in household garbageSabine Vogler, Roger H P F de Rooij
The Annals of Pharmacotherapy|September 3, 2016
Economic Evaluation of Hospital and Community Pharmacy ServicesTodd Gammie, Sabine Vogler, Zaheer-Ud-Din Babar
Cost Effectiveness and Resource Allocation : C/E|July 6, 2013
The role of discounts and loss leaders in medicine procurement in Austrian hospitals - a primary survey of official and actual medicine pricesSabine Vogler, Nina Zimmermann, Claudia Habl, et al.
Health Policy (Amsterdam, Netherlands)|February 6, 2026
Made in Europe - assessing the feasibility of reshoring active pharmaceutical ingredient production to EuropeVerena Knoll, Caroline Steigenberger, Stefan Fischer, et al.
Applied Health Economics and Health Policy|June 5, 2024
Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries GloballySabine Vogler, Katharina Habimana, Manuel Alexander Haasis, et al.
International Journal for Equity in Health|June 15, 2019
Affordable and equitable access to subsidised outpatient medicines? Analysis of co-payments under the Additional Drug Package in KyrgyzstanSabine Vogler, Peter Schneider, Guillaume Dedet, et al.
Southern Med Review|October 25, 2012
Pharmaceutical policies in European countries in response to the global financial crisisSabine Vogler, Nina Zimmermann, Christine Leopold, et al.
Frontiers in Pharmacology|July 12, 2021
Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical ExpenditureSabine Vogler, Peter Schneider, Martin Zuba, et al.
Frontiers in Pharmacology|April 20, 2017
Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the FutureKim Pauwels, Isabelle Huys, Sabine Vogler, et al.
Southern Med Review|October 25, 2012
Discounts and rebates granted to public payers for medicines in European countriesSabine Vogler, Nina Zimmermann, Claudia Habl, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Research in Social & Administrative Pharmacy : RSAP|February 18, 2018
Medication wasted - Contents and costs of medicines ending up in household garbageSabine Vogler, Roger H P F de Rooij
The Annals of Pharmacotherapy|September 3, 2016
Economic Evaluation of Hospital and Community Pharmacy ServicesTodd Gammie, Sabine Vogler, Zaheer-Ud-Din Babar
Cost Effectiveness and Resource Allocation : C/E|July 6, 2013
The role of discounts and loss leaders in medicine procurement in Austrian hospitals - a primary survey of official and actual medicine pricesSabine Vogler, Nina Zimmermann, Claudia Habl, et al.
Health Policy (Amsterdam, Netherlands)|February 6, 2026
Made in Europe - assessing the feasibility of reshoring active pharmaceutical ingredient production to EuropeVerena Knoll, Caroline Steigenberger, Stefan Fischer, et al.
Applied Health Economics and Health Policy|June 5, 2024
Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries GloballySabine Vogler, Katharina Habimana, Manuel Alexander Haasis, et al.
International Journal for Equity in Health|June 15, 2019
Affordable and equitable access to subsidised outpatient medicines? Analysis of co-payments under the Additional Drug Package in KyrgyzstanSabine Vogler, Peter Schneider, Guillaume Dedet, et al.
Southern Med Review|October 25, 2012
Pharmaceutical policies in European countries in response to the global financial crisisSabine Vogler, Nina Zimmermann, Christine Leopold, et al.
Frontiers in Pharmacology|July 12, 2021
Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical ExpenditureSabine Vogler, Peter Schneider, Martin Zuba, et al.
Frontiers in Pharmacology|April 20, 2017
Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the FutureKim Pauwels, Isabelle Huys, Sabine Vogler, et al.
Southern Med Review|October 25, 2012
Discounts and rebates granted to public payers for medicines in European countriesSabine Vogler, Nina Zimmermann, Claudia Habl, et al.
Pageof 6